Senegal could begin producing Covid-19 vaccines next year under an agreement with Belgian biotech group Univercells aimed at boosting Africa's drug-manufacturing ambitions, says a source involved in funding the project.
Image: ReutersA health worker receives a dose of the COVID-19 vaccine in Dakar.
Senegal could begin producing COVID-19 vaccines next year under an agreement with Belgian biotech group Univercells aimed at boosting Africa’s drug-manufacturing ambitions, a source involved in funding the project told
Reuters.
As wealthy countries begin to reopen after securing vaccine supplies early, African nations are still struggling to acquire shots. On a continent of 1.3 billion, only about 7 million have been fully vaccinated.
The collaboration highlights the opportunities created by a global push to channel money and technology towards production on a continent that makes only 1% of the vaccines it requires.
Deal aims to produce 300 mln doses of COVID vaccine by end
2022 Potential boon for Africa s tiny vaccine industry
DAKAR, June 6 (Reuters) - Senegal could begin producing
COVID-19 vaccines next year under an agreement with Belgian
biotech group Univercells aimed at boosting Africa s
drug-manufacturing ambitions, a source involved in funding the
project told Reuters.
As wealthy countries begin to reopen after securing vaccine
supplies early, African nations are still struggling to acquire
shots. On a continent of 1.3 billion, only about 7 million have
been fully vaccinated.
The collaboration highlights the opportunities created by a
global push to channel money and technology towards production